Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation.N Engl J Med. 2001; 345: 1794-1800
- HLA compatibility and organ transplant survival. Collaborative Transplant Study.Rev Immunogenet. 1999; 1: 334-342
- High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.Blood. 2007; 2007: 4576-4583
- Should HLA mismatch acceptability for sensitized transplant candidates be determined at the high-resolution rather than the antigen level?.Am J Transplant. 2015; 15: 923-930
- Major histocompatibility complex genomics and human disease.Annu Rev Genomics Hum Genet. 2013; 14: 301-323
- HLA and infectious diseases.Clin Microbiol Rev. 2009; 22: 370-385
- HLA-associated drug hypersensitivity and the prediction of adverse drug reactions.Pharmacogenomics. 2017; 18: 1441-1457
- The IPD and IMGT/HLA database: allele variant databases.Nucleic Acids Res. 2015; 43: D423-D431
- DNA sequencing with chain-terminating inhibitors.Proc Natl Acad Sci U S A. 1977; 74: 5463-5467
- Next-generation sequencing platforms.Annu Rev Anal Chem (Palo Alto Calif). 2013; 6: 287-303
- DNA sequencing: bench to bedside and beyond.Nucleic Acids Res. 2007; 35: 6227-6237
- Next-generation DNA sequencing methods.Annu Rev Genomics Hum Genet. 2008; 9: 387-402
- Sequencing technologies - the next generation.Nat Rev Genet. 2010; 11: 31-46
- Coming of age: ten years of next-generation sequencing technologies.Nat Rev Genet. 2016; 17: 333-351
- Next-generation DNA sequencing.Nat Biotechnol. 2008; 26: 1135-1145
- HLA typing by next-generation sequencing - getting closer to reality.Tissue Antigens. 2014; 83: 65-75
Illumina. Illumina sequencing platforms. Description of Illumina sequencers. 2018. Available at: https://www.illumina.com/systems/sequencing-platforms.html. Accessed April 26, 2018.
- 16(th) IHIW: review of HLA typing by NGS.Int J Immunogenet. 2013; 40: 72-76
- Towards allele-level human leucocyte antigens genotyping – assessing two next-generation sequencing platforms: Ion Torrent Personal Genome Machine and Illumina MiSeq.Int J Immunogenet. 2015; 42: 346-358
- Accurate whole human genome sequencing using reversible terminator chemistry.Nature. 2008; 456: 53-59
- High-resolution, high-throughput HLA genotyping by next-generation sequencing.Tissue Antigens. 2009; 74: 393-403
- Rapid high-throughput human leukocyte antigen typing by massively parallel pyrosequencing for high-resolution allele identification.Hum Immunol. 2009; 70: 960-964
- Next-generation sequencing for HLA typing of class I loci.BMC Genomics. 2011; 12: 42
- A multi-site study using high-resolution HLA genotyping by next generation sequencing.Tissue Antigens. 2011; 77: 206-217
- Next-generation sequencing: the solution for high-resolution, unambiguous human leukocyte antigen typing.Hum Immunol. 2010; 71: 1033-1042
- Preferential PCR amplification of alleles: mechanisms and solutions.PCR Methods Appl. 1992; 1: 241-250
- Report on the effects of fragment size, indexing, and read length on HLA sequencing on the Illumina MiSeq.Hum Immunol. 2015; 76: 897-902
- Determining performance characteristics of an NGS-based HLA typing method for clinical applications.HLA. 2016; 87: 141-152
- Performance characteristics and validation of next-generation sequencing for human leucocyte antigen typing.J Mol Diagn. 2016; 18: 668-675
- Dual redundant sequencing strategy: full-length gene characterisation of 1056 novel and confirmatory HLA alleles.HLA. 2017; 90: 79-87
- Impact of three Illumina library construction methods on GC bias and HLA genotype calling.Hum Immunol. 2015; 76: 166-175
- Next generation sequencing for clinical diagnostics-principles and application to targeted resequencing for hypertrophic cardiomyopathy: a paper from the 2009 William Beaumont Hospital Symposium on Molecular Pathology.J Mol Diagn. 2010; 12: 539-551
- Library construction for next-generation sequencing: overviews and challenges.Biotechniques. 2014; 56 (66, 68): 61-64
Illumina. Diagnosing and preventing flow cell overclustering on the MiSeq system. 2015. Available at: https://support.illumina.com/content/dam/illumina-marketing/documents/products/other/miseq-overclustering-primer-770-2014-038.pdf. Accessed December 24, 2015.
- Base-calling of automated sequencer traces using Phred. I. Accuracy assessment.Genome Res. 1998; 8: 175-185
- Base-calling of automated sequencer traces using Phred. II. Error probabilities.Genome Res. 1998; 8: 186-194
- Developing genome and exome sequencing for candidate gene identification in inherited disorders: an integrated technical and bioinformatics approach.Arch Pathol Lab Med. 2013; 137: 415-433
- Sequencing depth and coverage: key considerations in genomic analyses.Nat Rev Genet. 2014; 15: 121-132
- Efficient study design for next generation sequencing.Genet Epidemiol. 2011; 35: 269-277
- Initial sequencing and analysis of the human genome.Nature. 2001; 409: 860-921
- Oxford nanopore MinION sequencing and genome assembly.Genomics Proteomics Bioinformatics. 2016; 14: 265-279
- The sequence of sequencers: the history of sequencing DNA.Genomics. 2016; 107: 1-8
- HLA typing using next generation sequencing: an overview.Hum Immunol. 2015; 76: 887-890
- Advantages of genome sequencing by long-read sequencer using SMRT technology in medical area.Hum Cell. 2017; 30: 149-161
- DNA sequencing technologies: 2006-2016.Nat Protoc. 2017; 12: 213-218
- A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers.BMC Genomics. 2012; 13: 341
- Single molecule real-time DNA sequencing of HLA genes at ultra-high resolution from 126 International HLA and Immunogenetics Workshop cell lines.HLA. 2018; 91: 88-101
- A window into third-generation sequencing.Hum Mol Genet. 2010; 19: R227-R240
- Continuous base identification for single-molecule nanopore DNA sequencing.Nat Nanotechnol. 2009; 4: 265-270
- Three decades of nanopore sequencing.Nat Biotechnol. 2016; 34: 518-524
- The Oxford Nanopore MinION: delivery of nanopore sequencing to the genomics community.Genome Biol. 2016; 17: 239
- Rapid metagenomic identification of viral pathogens in clinical samples by real-time nanopore sequencing analysis.Genome Med. 2015; 7: 99
- Nanopore sequencing and assembly of a human genome with ultra-long reads.Nat Biotechnol. 2018; 36: 338-345
- Reading DNA at single-nucleotide resolution with a mutant MspA nanopore and phi29 DNA polymerase.Nat Biotechnol. 2012; 30: 349-353
- Molecule-hugging graphene nanopores.Proc Natl Acad Sci U S A. 2013; 110: 12192-12196
- Histoimmunogenetics markup language 1.0: reporting next generation sequencing-based HLA and KIR genotyping.Hum Immunol. 2015; 76: 963-974
- Minimum information for reporting next generation sequence genotyping (MIRING): guidelines for reporting HLA and KIR genotyping via next generation sequencing.Hum Immunol. 2015; 76: 954-962
- The impact of next-generation sequencing technologies on HLA research.J Hum Genet. 2015; 60: 665-673
- The dichotomy between disease phenotype databases and the implications for understanding complex diseases involving the major histocompatibility complex.Int J Immunogenet. 2015; 42: 413-422
Article info
Publication history
Published online: October 05, 2018
Footnotes
Disclosure: The authors have nothing to disclose.
Identification
Copyright
© 2018 Elsevier Inc. All rights reserved.
